• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We’re Reading: Hospital Pricing Transparency; Increasing Elder Care Expenses; New COVID Vaccine Faces Challenges

News
Article

Better transparency is needed for nonemergency hospital care expenses; services and support are needed to alleviate the financial strain of caring for older adults; a reduced demand for annual COVID-19 vaccination is putting pressure on public health officials.

Proposed Rules Aim to Facilitate Expense Prediction for Consumers

A satirical advertisement from advocacy group Patient Rights Advocate highlights ongoing concerns about hospital pricing transparency, according to Kaiser Health News. Despite a 2021 law requiring hospitals to publicly post prices, some still provide estimates rather than exact figures, leading to criticism from advocates. The Biden administration is proposing new rules to further standardize data, increase its usefulness for consumers, and boost enforcement. However, achieving exact price tags in every situation remains challenging due to the unique nature of medical care. The proposed rules aim to make it easier for consumers to predict their expenses for nonemergency hospital care, but the complexity of the data remains a challenge.

Caring for Aging Family Members a Financial Burden as Costs Rise

The rising costs of caring for older adults is creating financial challenges for many Americans, especially as the baby boomer generation ages, according to The Hill. The price of nursing home care has increased significantly in recent years, leading to concerns about the affordability of long-term care. There remains a lack of comprehensive options for those needing extensive around-the-clock care, although some solutions, such as the Washington Cares payroll tax—through which qualifying residents can receive up to $36,500 to help cover the cost of long-term care services—provide support.

Anticipated New COVID-19 Vaccine Facing Challenges

The upcoming rollout of a new COVID-19 vaccine aimed at combating the Eris variant is expected to face a cool reception, mirroring the declining demand for annual shots since the initial vaccine campaign in 2021, according to Reuters. Hospitalizations from this variant of Omicron are increasing, but many Americans say they have forgone annual vaccinations because of the protection they believe they still have from previous shots or infections. Health care providers and pharmacies will offer the updated shot starting in September, but concerns about the virus have waned, prompting public health officials to emphasize the ongoing risk and the need for annual protection, similar to that provided by the flu shot.

Related Videos
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Dr Chris Pagnani
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.